Pan American League of Associations for Rheumatology guidelines for the treatment of giant cell arteritis-Reference-Cited by-同舟云学术

Pan American League of Associations for Rheumatology guidelines for the treatment of giant cell arteritis

Published:2022-12 Issue:12 Volume:4 Page:e864-e872
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Scolnik Marina,Brance Maria L,Fernández-Ávila Daniel G,Inoue Sato Emilia,de Souza Alexandre W S,Magri Sebastián J,Saldarriaga-Rivera Lina M,Ugarte-Gil Manuel F,Flores-Suarez Luis F,Babini Alejandra,Zamora Natalia V,Acosta Felquer María L,Vergara Facundo,Carlevaris Leandro,Scarafia Santiago,Soriano Guppy Enrique R,Unizony Sebastian

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference70 articles.

1. Epidemiology of giant cell arteritis and polymyalgia rheumatica;Gonzalez-Gay;Arthritis Rheum,2009

2. Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities;Dejaco;Nat Rev Rheumatol,2017

3. Giant cell arteritis;Hoffman;Ann Intern Med,2016

4. Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients;Alba;Medicine (Baltimore),2014

5. Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study;Labarca;Rheumatology (Oxford),2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy of giant cell arteritis and polymyalgia rheumatica: Prospects for the use of monoclonal antibodies to interleukin 6;Rheumatology Science and Practice;2024-09-02

2. Ethanolic Extract of Equisetum arvense: A Potential Agent against Rheumatoid Arthritis in Wistar Rats with Freund’s Complete Adjuvant-Induced Arthritis;Indian Journal of Pharmaceutical Education and Research;2024-08-10

3. Relapses in giant cell arteritis: Updated review for clinical practice;Autoimmunity Reviews;2024-06

4. Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept study;The Lancet Rheumatology;2023-12

5. Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis;RMD Open;2023-04